Current Research Studies

If you are interested in participating in any of the clinical research studies listed below, please call (734) 677-6000, option 4 to speak with a research nurse (available between the hours of 8 a.m. and 5 p.m., Monday through Friday) or complete a study application form

Clinical Trials Now Enrolling

Fibromyalgia in Adults	Dr. Alicia Prestegaard is conducting a research study of an investigational medication for adults (age 18 and over) who have been diagnosed with Fibromyalgia.
Chronic Migraine Study	Dr. Joel Saper is recruiting men and women age 18 to 80 who experience chronic headaches (over 15 days/month).
Episodic Cluster Headache	Dr. Joel Saper is recruiting individuals 18 to 65 who have episodic cluster headaches to participate in a clinical trial utilizing an investigational non-invasive nerve stimulator for patients with episodic cluster headaches.
Post Traumatic Neuropathy	Dr. James Weintraub is conducting a clinical trial for individuals age 18 or older who have neuropathic pain (nerve pain) after a traumatic event or surgery (includes motor vehicle accident, fall, sports injury, knee or hip replacement, hernia repair, thoracotomy, mastectomy, burns or crush injury).
Spasticity due to Multiple Sclerosis	Dr. Erik Sinka is conducting a study of an experimental medication to treat spasticity associated with Multiple Sclerosis (MS).
Pain after Shingles Outbreak	Dr. James Weintraub is seeking individuals who continue to experience persistent pain after a shingles outbreak.
Teenagers with Headaches	Dr. Joel Saper is recruiting teenagers 12 to 17 to participate in an acute migraine study.
Acute Treatment of Migraine	Dr. Joel Saper is recruiting men and women ages 18-65 who experience intermittent headaches to participate in a clinical trial for the acute treatment of migraines.
Diabetic Peripheral Neuropathy	Dr. James Weintraub is currently recruiting individuals 18 years or older with inadequately treated Diabetic Peripheral Neuropathy.

FONT

Take Back Your Life

Schedule a New Patient appointment at MHNI

Read MHNI Patient Testimonials

Sleep Well Centers

Treatment for Sleep Disorders

MHNI Updates

Pre-registration is closed for Pain Management CE

Pre-registration is closed but spaces are still available in MHNI's popular medical/pharmacy continuing education course at The Henry in Dearborn, Michigan. Onsite registration opens at 7:15 a.m. on Friday, May 17, 2013 .

MHNI patients were not administered contaminated steroid

There has been a serious crisis in the use of methylprednisolone (steroid) for epidurals involving the neck and the back. Fortunately, steroids administered by MHNI did not originate from the contaminated source.

Participate in Research

CARF Joint Commision

MHNI is the first (and only) head pain treatment program nationally accredited by The Joint Commission and CARF International

Patients & Visitors

MHNI

You are here